PNPLA1 defects in patients with autosomal recessive congenital ichthyosis and KO mice sustain PNPLA1 irreplaceable function in epidermal omega-O-acylceramide synthesis and skin permeability barrier
Language English Country Great Britain, England Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
28369476
DOI
10.1093/hmg/ddx079
PII: 3091202
Knihovny.cz E-resources
- MeSH
- Ceramides metabolism MeSH
- Child MeSH
- Epidermis metabolism MeSH
- Extracellular Matrix metabolism MeSH
- Genes, Recessive MeSH
- Skin metabolism MeSH
- Ichthyosis, Lamellar genetics MeSH
- Middle Aged MeSH
- Humans MeSH
- Lipase genetics metabolism MeSH
- Lipid Metabolism MeSH
- Mice, Knockout MeSH
- Mice MeSH
- Permeability MeSH
- Aged MeSH
- Animals MeSH
- Check Tag
- Child MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Mice MeSH
- Aged MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Ceramides MeSH
- Lipase MeSH
- PNPLA1 protein, human MeSH Browser
- PNPLA1 protein, mouse MeSH Browser
Autosomal recessive congenital ichthyosis (ARCI) is a heterogeneous group of monogenic genodermatoses that encompasses non-syndromic disorders of keratinization. The pathophysiology of ARCI has been linked to a disturbance in epidermal lipid metabolism that impaired the stratum corneum function, leading to permeability barrier defects. Functional characterization of some genes involved in ARCI contributed to the identification of molecular actors involved in epidermal lipid synthesis, transport or processing. Recently, PNPLA1 has been identified as a gene causing ARCI. While other members of PNPLA family are key elements in lipid metabolism, the function of PNPLA1 remained unclear. We identified 5 novel PNPLA1 mutations in ARCI patients, mainly localized in the putative active enzymatic domain of PNPLA1. To investigate Pnpla1 biological role, we analysed Pnpla1-deficient mice. KO mice died soon after birth from severe epidermal permeability defects. Pnpla1-deficient skin presented an important impairment in the composition and organization of the epidermal lipids. Quantification of epidermal ceramide species highlighted a blockade in the production of ω-O-acylceramides with a concomitant accumulation of their precursors in the KO. The virtually loss of ω-O-acylceramides in the stratum corneum was linked to a defective lipid coverage of the resistant pericellular shell encapsulating corneocytes, the so-called cornified envelope, and most probably disorganized the extracellular lipid matrix. Finally, these defects in ω-O-acylceramides synthesis and cornified envelope formation were also evidenced in the stratum corneum from PNPLA1-mutated patients. Overall, our data support that PNPLA1/Pnpla1 is a key player in the formation of ω-O-acylceramide, a crucial process for the epidermal permeability barrier function.
Centre for Applied Sciences at Technical Universities 68163 Mannheim Germany
MetaToul Lipidomic Core Facility Inserm U1048 Toulouse France
Plateforme de Microscopie Électronique Intégrative CNRS FR3743 Bat IBCG F 31062 Toulouse France
Reference Centre for Rare Skin Diseases Larrey Hospital Toulouse France
References provided by Crossref.org